Total Debt
$634K
Net Debt
-$255.4M
Atea Pharmaceuticals, Inc. currently has $634K in total debt. Net debt is -$255.4M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.
Financial Fundamentals
AVIR • Quarterly Data • 5Y View
| Date | Total Debt ($B) | Cash & Inv. ($B) | Net Debt ($B) | Total Assets | Debt/Assets |
|---|---|---|---|---|---|
| 2026-03-31 | 0.00 | 0.26 | -0.26Net Cash | 0.27 | 0.2% |
| 2025-12-31 | 0.00 | 0.30 | -0.30Net Cash | 0.32 | 0.3% |
| 2025-09-30 | 0.00 | 0.33 | -0.33Net Cash | 0.34 | 0.3% |
| 2025-06-30 | 0.00 | 0.38 | -0.38Net Cash | 0.39 | 0.3% |
| 2025-03-31 | 0.00 | 0.43 | -0.42Net Cash | 0.44 | 0.3% |
| 2024-12-31 | 0.00 | 0.45 | -0.45Net Cash | 0.46 | 0.4% |
| 2024-09-30 | 0.00 | 0.48 | -0.48Net Cash | 0.49 | 0.4% |
| 2024-06-30 | 0.00 | 0.50 | -0.50Net Cash | 0.51 | 0.4% |
| 2024-03-31 | 0.00 | 0.54 | -0.54Net Cash | 0.55 | 0.4% |
| 2023-12-31 | 0.00 | 0.58 | -0.58Net Cash | 0.59 | 0.4% |
| 2023-09-30 | 0.00 | 0.60 | -0.59Net Cash | 0.61 | 0.4% |
| 2023-06-30 | 0.00 | 0.61 | -0.61Net Cash | 0.63 | 0.4% |
| 2023-03-31 | 0.00 | 0.62 | -0.62Net Cash | 0.64 | 0.5% |
| 2022-12-31 | 0.00 | 0.65 | -0.64Net Cash | 0.67 | 0.5% |
| 2022-09-30 | 0.00 | 0.66 | -0.66Net Cash | 0.69 | 0.5% |
| 2022-06-30 | 0.00 | 0.68 | -0.68Net Cash | 0.69 | 0.5% |
| 2022-03-31 | 0.00 | 0.71 | -0.70Net Cash | 0.72 | 0.4% |
| 2021-12-31 | 0.00 | 0.76 | -0.76Net Cash | 0.77 | 0.0% |
| 2021-09-30 | 0.00 | 0.84 | -0.84Net Cash | 0.84 | 0.0% |
| 2021-06-30 | 0.00 | 0.82 | -0.82Net Cash | 0.87 | 0.0% |
| 2021-03-31 | 0.00 | 0.83 | -0.83Net Cash | 0.84 | 0.1% |
| 2020-12-31 | 0.00 | 0.85 | -0.85Net Cash | 0.86 | 0.0% |
| 2020-09-30 | 0.00 | 0.11 | -0.11Net Cash | 0.11 | 0.0% |
| 2020-06-30 | 0.00 | 0.12 | -0.12Net Cash | 0.12 | 0.0% |
| 2020-03-31 | 0.00 | 0.02 | -0.02Net Cash | 0.02 | 0.0% |
| 2019-12-31 | 0.00 | 0.02 | -0.02Net Cash | 0.02 | 0.0% |